Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRRC8D mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | multiple interactions | ISO | Lrrc8d (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRRC8D mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of LRRC8D mRNA | CTD | PMID:22206623 | 1,4-dichlorobenzene | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | 4-dichlorobenzene results in increased expression of LRRC8D mRNA | CTD | PMID:26975756 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of LRRC8D mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of LRRC8D mRNA | CTD | PMID:17404688 and PMID:30165855 | 17beta-estradiol | affects expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Estradiol affects the expression of LRRC8D mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LRRC8D mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LRRC8D mRNA | CTD | PMID:33387578 and PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Lrrc8d (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRRC8D mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LRRC8D mRNA | CTD | PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LRRC8D mRNA | CTD | PMID:21570461 | 2,4-diaminotoluene | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in increased expression of LRRC8D mRNA | CTD | PMID:20713471 | 2,6-dinitrotoluene | affects expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of LRRC8D mRNA | CTD | PMID:21346803 | 3-methylcholanthrene | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of LRRC8D mRNA | CTD | PMID:20713471 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Lrrc8d (Mus musculus) | 6480464 | bisphenol S results in increased methylation of LRRC8D exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | bisphenol S results in increased expression of LRRC8D mRNA | CTD | PMID:37611474 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Lrrc8d (Mus musculus) | 6480464 | bisphenol S affects the methylation of LRRC8D gene | CTD | PMID:31683443 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Fenretinide results in decreased expression of LRRC8D mRNA | CTD | PMID:28973697 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of LRRC8D mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of LRRC8D intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of LRRC8D mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of LRRC8D mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of LRRC8D mRNA | CTD | PMID:33212167 | avobenzone | decreases expression | EXP | | 6480464 | avobenzone results in decreased expression of LRRC8D mRNA | CTD | PMID:31016361 | benzo[a]pyrene | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LRRC8D mRNA | CTD | PMID:20713471 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of LRRC8D 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of LRRC8D 3' UTR and Benzo(a)pyrene results in decreased methylation of LRRC8D exon | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of LRRC8D mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20382639 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of LRRC8D intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LRRC8D mRNA | CTD | PMID:29275510 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of LRRC8D gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LRRC8D gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of LRRC8D mRNA | CTD | PMID:34947998 | cadmium dichloride | decreases methylation | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of LRRC8D promoter | CTD | PMID:22457795 | cadmium dichloride | decreases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of LRRC8D mRNA | CTD | PMID:33453195 | chlorpyrifos | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of LRRC8D mRNA | CTD | PMID:32715474 and PMID:37019170 | choline | multiple interactions | ISO | Lrrc8d (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC8D gene | CTD | PMID:20938992 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of LRRC8D mRNA | CTD | PMID:19320972 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of LRRC8D mRNA | CTD | PMID:25351596 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of LRRC8D mRNA | CTD | PMID:20106945 and PMID:25562108 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of LRRC8D gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of LRRC8D mRNA | CTD | PMID:21266533 | dioxygen | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of LRRC8D mRNA | CTD | PMID:24205000 | dioxygen | affects methylation | ISO | Lrrc8d (Mus musculus) | 6480464 | Oxygen deficiency affects the methylation of LRRC8D promoter | CTD | PMID:24205000 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of LRRC8D mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of LRRC8D mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Ethanol affects the expression of LRRC8D mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Fenthion results in decreased expression of LRRC8D mRNA | CTD | PMID:34813904 | fipronil | decreases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of LRRC8D mRNA | CTD | PMID:34044035 | fluoranthene | multiple interactions | ISO | Lrrc8d (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC8D mRNA | CTD | PMID:28329830 | flutamide | increases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of LRRC8D mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Lrrc8d (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LRRC8D gene | CTD | PMID:31601247 | glafenine | decreases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Glafenine results in decreased expression of LRRC8D mRNA | CTD | PMID:24136188 | hypochlorous acid | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of LRRC8D mRNA | CTD | PMID:19376150 | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of LRRC8D mRNA | CTD | PMID:35984750 | L-methionine | multiple interactions | ISO | Lrrc8d (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC8D gene | CTD | PMID:20938992 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of LRRC8D mRNA | CTD | PMID:28988120 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of LRRC8D intron | CTD | PMID:30157460 | methidathion | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | methidathion results in increased expression of LRRC8D mRNA | CTD | PMID:34813904 | methoxychlor | affects methylation | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of LRRC8D gene | CTD | PMID:35440735 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of LRRC8D mRNA | CTD | PMID:23649840 | oxaliplatin | multiple interactions | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of LRRC8D mRNA | CTD | PMID:25729387 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of LRRC8D mRNA | CTD | PMID:35430440 | paracetamol | affects expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Acetaminophen affects the expression of LRRC8D mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of LRRC8D mRNA | CTD | PMID:22230336 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of LRRC8D mRNA | CTD | PMID:32588087 | phenobarbital | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Phenobarbital results in increased expression of LRRC8D mRNA | CTD | PMID:19270015 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LRRC8D mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of LRRC8D mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRRC8D mRNA | CTD | PMID:22079256 | progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of LRRC8D mRNA | CTD | PMID:17404688 | prothioconazole | increases expression | EXP | | 6480464 | prothioconazole results in increased expression of LRRC8D mRNA | CTD | PMID:35048155 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of LRRC8D mRNA | CTD | PMID:21632981 | resorcinol | decreases expression | EXP | | 6480464 | resorcinol results in decreased expression of LRRC8D mRNA | CTD | PMID:22623647 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of LRRC8D mRNA | CTD | PMID:32178731 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of LRRC8D mRNA | CTD | PMID:25351596 | sodium arsenite | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of LRRC8D mRNA | CTD | PMID:37682722 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of LRRC8D mRNA | CTD | PMID:31533062 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of LRRC8D mRNA | CTD | PMID:31758290 | thioacetamide | decreases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of LRRC8D mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | titanium dioxide results in increased expression of LRRC8D mRNA | CTD | PMID:23557971 | topotecan | decreases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of LRRC8D mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of LRRC8D mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | ISO | Lrrc8d (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of LRRC8D mRNA | CTD | PMID:33387578 | tungsten | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Tungsten results in decreased expression of LRRC8D mRNA | CTD | PMID:30912803 | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of LRRC8D mRNA | CTD | PMID:29453283 | valproic acid | affects expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Valproic Acid affects the expression of LRRC8D mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | ISO | Lrrc8d (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of LRRC8D mRNA | CTD | PMID:19136453 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of LRRC8D mRNA | CTD | PMID:25979313 | |